Example collocations logo

Patent in sentence

392 examples of Patent in a sentence

But even if the ISCC’s patent applications are not excluded on these grounds, there is another potential roadblock for applicants: Under European law, an invention can be patented only if its commercial exploitation is deemed not to controvert “ordre public” or morality.
They should not, it now seems clear, be left to the patent office or even the courts.
In fact, the European Patent Office (EPO) is not particularly committed to assessing the moral implications of the patents it grants; in its view, “ordre public” would be violated only in the extreme case of a truly outrageous invention.
As a result, while the application procedure allows for third parties to submit to the patent office their observations on the claimed invention’s patentability, it is unlikely to spur a genuine assessment of an application’s moral implications.
An opposing third party would have to shoulder the entire burden of proof, while the patent office avoided taking any real action, in order to avoid “presumptuous” interference in the public debate.
There are also pending patent applications for a novel form of genetic manipulation – CRISPR/Cas9-mediated gene editing – which a team of Chinese researchers has already attempted to use to edit the genome of a human embryo.
These prohibitions are based not just on the need to protect human embryos, but also on concerns relating to the availability of donated egg cells, on which parthenogenesis depends – an issue that neither the courts nor the patent office have considered.
But from the outset of the intervention, coalition officials have displayed patent disregard for mass graves and massacre sites.
One example, flagged by the economist Jeffrey Sachs, is Sovaldi, a drug used to cure hepatitis C. As Sachs explains, the company that sells it, Gilead Sciences, holds a patent for the treatment that will not expire until 2028.
Other approaches are also possible: tightening up patent laws or imposing price controls for monopolistic industries, such as pharmaceuticals, as many market economies have done.
As a result, a new antibiotic may not become widely used until after its patent has expired and its inventors are forced to compete with generic manufacturers.
With new patent laws coming into place, India will have the same attraction for the pharmaceutical industry as it has for IT, providing clinical trials for new drugs at a quarter of the cost of Europe or the US.
As a result, Chinese may operate family farms, own homes and businesses, control their educational choices, patent inventions, and amass fortunes.
Dutch firms are also world patent leaders;Eindhoven, the hometown of the electronics company Philips, is the world’s most patent-intensive city.
In 2013, for example, resident inventors in Germany filed some 917 patent applications for every million inhabitants.
Resident inventors in Greece, by contrast, filed just 69 patent applications for every million.
But then the TPP’s boosters have to contend with the obstinacy of Japanese rice farmers (Prime Minister Shinzo Abe is vowing to address that) and of US patent and copyright holders.
It also wants technical changes that would effectively mean much longer patent terms for pharmaceuticals, make the approval process lengthier for generic drug makers, and extend protections for biologic medicines.
In this sense, the US demand for longer terms of patent and copyright protection is arbitrary, because they are not founded on a clear-cut case for enhanced economic efficiency.
With the TPP, Vietnam gets some assurance of continued access to the US market (existing barriers on the US side are already quite low), but in return must submit to restrictions on subsidies, patent rules, and investment regulations.
More broadly, there is increasing recognition that the patent system, as currently designed, not only imposes untold social costs, but also fails to maximize innovation – as Myriad’s gene patents demonstrate.
A poorly designed patent system – like the one we have now – can inhibit follow-on research.
In the late 1980s, the leading industrialized countries – the United States, Europe, and Japan – began to push for stronger patent regimes that would boost their own pharmaceutical companies’ profits.
Moreover, under Section 301 of the US Trade Act of 1974, sanctions were imposed on several developing countries, from Chile to India, accused of failing to strengthen patent protections sufficiently.
Even when the AIDS crisis was ravaging Sub-Saharan Africa in the early 2000s, global patent rules were not just maintained, but actually tightened further, until pressure from civil society finally forced the expansion of access to affordable treatment.
Lastly, some argue that if farmers are permitted to sow GM varieties, they become dependent on large seed producers such as Monsanto, which have patent protection – and thus a monopoly – on the seed.
While some pharmacologists dedicate their lives to searching for the cure for cancer, regardless of any monetary incentives, many are driven by the hope of securing a lucrative patent.
If Nokia had immediately begun to develop products modeled after the iPhone, while addressing related patent issues effectively, the mobile-device business would look very different today.
There was patent gloating about the German defeat everywhere, only thinly disguised behind strained expressions of solidarity.
Myriad Genetics, the sole test provider in the US – it holds a patent on the genes themselves , not just on the diagnostic test – did not accept her insurance, and Ceriani could not afford to pay for the test.
BackNext